A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma

Clinical trial NCT02702141 · TERMINATED

Trial details

NCT number: NCT02702141
Sponsor: Seagen Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma DLBCL Diffuse Large B-cell Lymphoma Grade 3 Follicular Lymphoma

Start date: 2016-02-01
Primary completion: 2018-07-10
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.